Market Vectors Pharmaceutical ETF (PPH)

  • Loading...

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Good

Fund Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Fund Snapshot Updated 04.23.2014

Previous Close $59.17 Expense Ratio 0.35%
YTD Return 12.24% Avg. 30-Day Volume 81,321
1-Year Return 30.2% Market Cap Loading...
Bid $59.14 Shares Outstanding 5,438,000
Ask $59.26 Dividends $1.05
Top 10 Holdings
Johnson & Johnson (JNJ) 9.50%
Novartis A G (NVS) 8.78%
Pfizer Inc (PFE) 6.98%
Allergan Inc (AGN) 5.73%
Merck & Co Inc New (MRK) 5.22%
Sanofi (SNY) 5.18%
Glaxosmithkline Plc (GSK) 4.96%
Novo-Nordisk A S (NVO) 4.83%
Abbvie Inc (ABBV) 4.80%
Teva Pharmaceutical Inds Ltd (TEVA) 4.57%
% of Total Holdings 60.50%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds